Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vildagliptin plus short-term insulin pump therapy in newly diagnosed type 2 diabetes
ChiCTR-TRC-12002553Phase 4Completed
- Sponsor
- Nanfang Hospital, Southern Medical University
- Start
- Oct 2012
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of vildagliptin and human insulin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Nanfang Hospital, Southern Medical University. Primary endpoints: HbA1c, blood glucose and 9 more. Started Oct 2012; status: completed.
02
Drugs
vildagliptinhuman insulin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR-TRC-12002553.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12002553.